Wells Fargo
MRTX

Wells Fargo’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Wells Fargo’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,600
Closed -$1.55M – 8099
2021
Q4 		$1.55M Buy
+10,600
New +$1.65M ﹤0.01% 3740

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Wells Fargo's MRTX Position: Q1 2024 in Review

Wells Fargo sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 9,665 shares — an estimated $568K sold.

Wells Fargo first reported a position in MRTX in Q3 2013 and held it in 41 quarters. The position peaked at $66M in Q4 2020. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Wells Fargo reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Wells Fargo sold 9,665 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $568K.
  • Wells Fargo first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2013 and held it in 41 quarters.
  • Wells Fargo's Mirati Therapeutics, Inc. Common Stock position peaked at $66M in Q4 2020.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Wells Fargo's 13F filing for Q1 2024, filed 10 May 2024.